title: Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
authors.forename: D
authors.initials: D
authors.lastname: Larrey
authors.forename: P
authors.initials: P
authors.lastname: Marcellin
authors.forename: E
authors.initials: E
authors.lastname: Fréneaux
authors.forename: D
authors.initials: D
authors.lastname: Pessayre
authors.forename: J P
authors.initials: JP
authors.lastname: Benhamou
mesh_terms: D000328:Adult; D006526:Hepatitis C / Q000628:therapy; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D009103:Multiple Sclerosis / Q000503:physiopathology*; D011994:Recombinant Proteins
chemical_list: D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins